News Coverage 07.23.19 By: Amber Tong Share on Twitter Share on Facebook Share on LinkedIn PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Related Announcement, From Bench to Fireside From NK Cell Biology to a Career in Breakthrough Science with Lewis Lanier, PhD Announcement, From Bench to Fireside Introducing: From Bench to Fireside Announcement PICI Network at #SITC23
Announcement, From Bench to Fireside From NK Cell Biology to a Career in Breakthrough Science with Lewis Lanier, PhD